(4-Bromo-2-(trifluoromethoxy)phenyl)boronic acid, 98%, 1g

7-Trifluoromethyl-1H-indole-2-carboxylic acid, 95.0%, 250mg

trans-2,2-Dimethyl-3-heptene>99.0%(GC)5mL

[1,4']Bipiperidinyl-4-ol, 95.0%, 1g

tert-Butyl 4-(4-(trifluoromethyl)benzoyl)piperidine-1-carboxylate, 97%, 250mg

9-Azajulolidine>97.0%(GC)1g

Cyclohexanecarbonitrile, 95.0%, 5g

(1S)-2′-[[(1-Methylethyl)amino]carbonyl][1,1′-binaphthalene]-2-carboxylic acid, 100mg

N,N-dimetilformammide, minimo 99,5%, per sintesi, 10 l, confezione in plastica.

2-(AZETIDIN-3-YLOXY)PYRIDINE HCL, 95%, 250g

5-(2-Hydroxybenzoyl)-2-oxo-1-(1,3-thiazol-2-yl)-1,2-dihydropyridine-3-carbonitrile, 97%, 250mg

2,3-Difluorobenzoic Acid>98.0%(GC)(T)25g

1-Bromo-4-(difluoromethyl)-2-fluorobenzene, 97.0%, 5g